InspireMD (NSPR) Misses Q2 EPS by 2c

InspireMD (NYSE: NSPR) reported Q2 EPS of ($0.19), $0.02 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $540 thousand versus the consensus estimate of $800 thousand.

For earnings history and earnings-related data on InspireMD (NSPR) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Element Solutions (ESI) PT Lowered to $47 at UBS, Buy Rating Maintained
• Corpay agrees to $100M FTC settlement over marketing practices